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Abstract
After stone removal, accurate analysis of urinary stone composition is the most crucial labo-
ratory diagnostic procedure for the treatment and recurrence prevention in the stone-form-
ing patient. The most common techniques for routine analysis of stones are infrared
spectroscopy, X-ray diffraction and chemical analysis. The aim of the present study was to
assess the quality of urinary stone analysis of laboratories in Europe. Nine laboratories from
eight European countries participated in six quality control surveys for urinary calculi analy-
ses of the Reference Institute for Bioanalytics, Bonn, Germany, between 2010 and 2014.
Each participant received the same blinded test samples for stone analysis. A total of 24
samples, comprising pure substances and mixtures of two or three components, were ana-
lysed. The evaluation of the quality of the laboratory in the present study was based on the
attainment of 75% of the maximum total points, i.e. 99 points. The methods of stone analy-
sis used were infrared spectroscopy (n = 7), chemical analysis (n = 1) and X-ray diffraction
(n = 1). In the present study only 56% of the laboratories, four using infrared spectroscopy
and one using X-ray diffraction, fulfilled the quality requirements. According to the current
standard, chemical analysis is considered to be insufficient for stone analysis, whereas
infrared spectroscopy or X-ray diffraction is mandatory. However, the poor results of infra-
red spectroscopy highlight the importance of equipment, reference spectra and qualification
of the staff for an accurate analysis of stone composition. Regular quality control is essential
in carrying out routine stone analysis.
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Introduction
Prevalence and incidence of urolithiasis in industrialized countries have markedly increased
over the past decades. The prevalence of urinary stone disease in the Unites States significantly
increased from 5.2% in 1988 to 1994 to 8.8% in 2007 to 2010 [1,2]. In Japan, a rise in the preva-
lence from 4.0% to 5.4% was observed within 10 years [3]. In Germany, the prevalence of uro-
lithiasis markedly increased from 4.0% to 4.7% and the incidence from 0.54% to 1.47%
between 1979 and 2001 [4].
The recurrence rate of urinary stones is estimated to be up to 42% [4,5,6]. The high inci-
dence of recurrence indicates that metaphylactic measures after stone removal are still inade-
quate. Patients at high risk of recurrent stone formation are those with infection stones, uric
acid, urate (i.e. monoammonium urate, monopotassium urate and monosodium urate mono-
hydrate), brushite and genetically determined stones (i.e. cystine, 2,8-dihydroxyadenine and
xanthine stones) [7]. Depending on different risk factors, calcium oxalate stone disease is like-
wise characterised by a high frequency of recurrence [8]. For effective management of the
stone-forming patient, accurate stone analysis is, therefore, an essential component of the diag-
nostic work-up and a prerequisite of metabolic evaluation [9].
According to the EAU guidelines (2015), all patients should have at least one stone analysed
[7]. As the stone composition has significant therapeutic importance in the evaluation of
patients, all urinary stones should be analysed [10]. Different techniques have been used for the
compositional analysis of urinary stones, including X-ray diffraction (XD), infrared spectros-
copy (IR) and chemical analysis (CA). Whereas IR is used for the examination of chemical
molecular structures, XD is used for the determination of the crystalline structure of a sub-
stance. For the correct analysis of stone composition, IR and XD offer the highest degree of cer-
tainty. Due to poor results, wet chemical analysis of urinary stones is considered to be obsolete
[10].
Urinary stones are often composed of more than one substance, which presents a difficulty
in accurate assessment of the stone composition. A study performed in the United States found
that commercial laboratories reliably recognised pure calculi, whereas variability in the report-
ing of mixtures was observed [11]. Analysis of more than 10.000 human urinary calculi
revealed that only 7% of stones consisted of just one component [12], reflecting the clinical rel-
evance of such a test variability.
Data regarding the accuracy of urinary stone analysis in Europe is lacking, stressing the
importance of quality assessment of stone analysis in Europe. The application of analytical
methods for stone analysis and the quality of the results were evaluated in nine European
stone analysis laboratories participating in quality control surveys for urinary calculi
analyses.
Materials and Methods
Nine urinary stone analysis laboratories from eight European countries (Denmark, France,
Germany, Italy, Portugal, Switzerland, Turkey and United Kingdom) participated in six quality
control surveys for urinary calculi analyses by the Reference Institute for Bioanalytics (RfB),
Bonn, Germany, between 2010 and 2014. Of the nine laboratories, four had already partici-
pated in previous quality control surveys conducted by the RfB. Each participant received the
same 24 blinded test samples for stone analysis to allow for direct comparison.
All laboratories advertised the use of their method for stone analysis. The certification of the
analytical results by the RfB was based primarily on the correct qualitative proof of the sub-
stances present in each sample. A correct result required precise qualitative determination in
mixtures at 10% gradations. For evaluation, the following scoring system was used:
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Simplified analysis results (e.g. calcium oxalate instead of calcium oxalate monohydrate or
calcium oxalate dihydrate; calcium phosphate instead of carbonate apatite, apatite, brushite or
whitlockite; uric acid instead of uric acid dihydrate) scored with half of the possible points.
In order to get the certificate for each survey, at least 75% of the maximum points were
needed. If the analysis of the laboratory yielded only simplified analyses results (e.g. calcium
oxalate instead of calcium oxalate monohydrate or calcium oxalate dihydrate), then the labora-
tory would normally fail in achieving the required number of points. A total of 132 points
could be maximally achieved by each laboratory after participation in the present six surveys.
The evaluation of the quality of a laboratory in the present study was based on the attainment
of 75% of the maximum total points, i.e. 99 points.
The samples used as test substances, single components and mixtures are shown in Table 1.
The mixtures comprised two or three components of varying percentages by weight. While the
majority of the samples were synthetic, the reference material for the remaining samples con-
sisted of native urinary calculi. The use of synthetic products as test substances is necessary, as
sufficient amounts of native urinary stone material are rarely available in the high quantities
needed for the large number of participants in these surveys. The advantage of synthetic mate-
rial is that these substances are standardised for purity and crystallinity, whereas urinary stones
frequently contain mixtures and differ strongly in their crystallinity [13]. The test substances
for the quality control surveys for urinary calculi analyses of the RfB were obtained from Dr. G.
Schubert, Vivantes Klinikum im Friedrichshain, Institute of Laboratory Diagnostics, Berlin,
Germany.
Results
The method of analysis most frequently used by participating laboratories was IR (n = 7). One
laboratory reported the application of XD and another of CA. The comparison of the analytical
results of the nine laboratories and the correct composition of the samples for stone analysis
are presented in Table 2. The error rates of qualitative analysis for test substances of single
components and components in mixtures are shown in Table 3.
The error rate of up to 100% was extremely high for the laboratory using CA. Regarding the
most common stone components (i.e. whewellite, uric acid and apatite), the error rate for CA
was between 80 and 100%. IR showed incorrect results in up to 86% of the analyses. Although
XD provided correct detection of each substance, the laboratory did not receive the maximum
total points of 132 due to 2 false-positive analyses of substances.
Whewellite, one of the most common stone components, was either not found or wrongly
identified in 36% (32 of 90) of analyses. The error rates were 33% (23 of 70) for IR, 90% for CA
and 0% for XD.
Seventy-three percent of all participants reliably recognised uric acid. However, only 61%
(11 of 18) of analyses correctly identified the component uric acid dihydrate. The error rates in
the case of uric acid and uric acid dihydrate when using IR were 23% and 36%, respectively.
The laboratory using CA did not identify uric acid dihydrate, whereas the laboratory with XD
correctly reported uric acid and uric acid dihydrate.
Substance present  80% +4 points
Substance present between 30 and 70% +3 points
Substance present  20% +2 points
per false analysis (but the score for one sample cannot become negative) -1 point
doi:10.1371/journal.pone.0156606.t001
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Brushite was reliably recognized in nearly 80% and apatite in 86% of analyses. Whereas the
laboratory using CA was unable to identify brushite and apatite, XD correctly provided detec-
tion of both substances in mixtures. Error rates regarding analyses of brushite and apatite were
14% and 4%, respectively, for IR.
Table 1. Test substances for analysis.
Sample Proportion Chemical name Mineralogical name Reference material
Pure
1 100% Calcium carbonate (n = 2) Calcite Fluka
2 100% Calcium phosphate Whitlockite Fluka
3 100% Cholesterol (n = 2) - Aldrich
4 100% Monopotassium urate - Sigma
5 100% Monosodium urate monohydrate - Sigma
6 100% Sucrose Cristal sugar Cristal sugar
Two components
7 70% Calcium hydrogen phosphate dihydrate Brushite Fluka
30% Calcium oxalate monohydrate Whewellite
8 50% Calcium hydrogen phosphate dihydrate Brushite Fluka
50% Calcium oxalate monohydrate Whewellite
9 60% Calcium hydrogen phosphate dihydrate Brushite Fluka
40% Apatite Apatite
10 70% Calcium oxalate monohydrate Whewellite Native urinary calculus
30% Apatite Apatite
11 60% Cystine - Fluka
40% Calcium oxalate monohydrate Whewellite
12 20% Cystine - Fluka
80% Calcium oxalate monohydrate Whewellite
13 70% Magnesium ammonium phosphate hexahydrate Struvite Native urinary calculus
30% Apatite (n = 2) Apatite
14 30% Magnesium ammonium phosphate hexahydrate Struvite Native urinary calculus
70% Apatite Apatite
15 60% Uric acid dihydrate - Native urinary calculus
40% Uric acid Uricite
16 30% Uric acid dihydrate - Native urinary calculus
70% Uric acid Uricite
17 80% Uric acid Uricite Native urinary calculus
20% Calcium oxalate monohydrate Whewellite
18 70% Uric acid Uricite Fluka
30% Calcium oxalate monohydrate Whewellite
19 50% Uric acid Uricite Native urinary calculus
50% Calcium oxalate monohydrate Whewellite
Three components
20 50% Calcium oxalate dihydrate Weddellite Native urinary calculus
30% Calcium oxalate monohydrate Whewellite
20% Apatite Apatite
21 50% Magnesium ammonium phosphate hexahydrate Struvite Native urinary calculus
30% Apatite Apatite
20% Calcium oxalate monohydrate Whewellite
doi:10.1371/journal.pone.0156606.t002
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Table 2. Comparison of analytical results of nine laboratories and the correct composition of samples for stone analysis.
Lab A Lab B Lab C Lab D Lab E Lab F Lab G Lab H Lab I
XD IR IR IR IR IR IR IR CD
Sample Substances % % % % % % % % % %
Survey 1
A Cholesterol 100 100 100 100 100 100 100 0 0 0
False analysis - - - - - - - 100 MP 100 AF 100 NI
B Uric acid dihydrate 60 50 50 0 60 30 0 0 0 0
Uricite 40 50 50 80 40 60 0 0 100 100
False analysis - - - 20 WD - 10 WH 100 UA 100 UA - -
C Brushite 50 60 70 50 60 30 50 100 50 0
Whewellite 50 40 30 50 40 50 0 0 0 40
False analysis - - - - - 20 WD 50 CaOx - 50 WD 30 WD
False analysis - - - - - - - - - 30 AP
D Monopotassium urate 100 100 100 100 100 100 0 0 0 0
False analysis - - - - - - 100 UA 100 MU 100 MU 100 NI
Survey 2
A Calcite 100 100 100 100 100 100 100 100 0 0
False analysis - - - - - - - - 100 NI 100 NI
B Uricite 50 30 60 50 70 35 0 100 50 0
Whewellite 50 70 30 50 30 65 0 0 50 0
False analysis - - 10 UD - - - 65 CaOx - - 100 NI
False analysis - - - - - - 35 UA - - -
C Cystine 60 80 60 60 60 55 70 100 90 100
Whewellite 40 20 40 40 40 45 0 0 10 0
False analysis - - - - - - 30 CaOx - - -
D Whitlockite 100 90 100 0 0 0 0 0 0 0
False analysis - 10 NI - 100 NI 100 NI 100 AF 100 CP 100 NI 100 NI 100 NI
Survey 3
A Whewellite 70 70 30 40 40 55 0 25 60 0
Apatite 30 30 70 60 60 40 65 75 40 0
False analysis - - - - - 5 PR 35 CaOx - - 100 NI
B Struvite 70 80 80 60 80 50 0 35 40 0
Apatite 30 20 20 40 20 40 25 65 60 0
False analysis - - - - - 10 PR 75 MP - - 100 NI
C Weddellite 50 40 40 40 40 65 0 0 85 0
Whewellite 30 40 30 30 40 20 0 50 0 0
Apatite 20 20 30 30 20 15 10 50 15 0
False analysis - - - - - - 90 CaOx - - 100 NI
D Struvite 50 20 20 30 60 20 0 100 10 0
Apatite 30 70 70 70 30 70 45 0 75 0
Whewellite 20 10 10 0 0 10 0 0 10 0
False analysis - - - - 10 WD - 55 MP - 5 WD 100 NI
Survey 4
A Whewellite 80 70 60 80 70 90 0 0 100 0
Cystine 20 30 40 20 30 10 50 95 0 100
False analysis - - - - - - 50 CaOx 5 BR - -
B Cholesterol 100 100 100 100 100 100 100 0 0 0
False analysis - - - - - - - 100 CY 100 NI 100 NI
C Monosodium urate monohydrate 100 100 100 100 100 100 100 100 100 0
(Continued)
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The single components comprised the biliary calculus substance cholesterol, the rare stone
components whitlockite, monopotassium urate, monosodium urate monohydrate and calcium
carbonate and the artifact sucrose, which occasionally occurs in stone analysis laboratories.
Error rates of up to nearly 80% of all analyses were recorded. Whereas the laboratory using XD
correctly determined each of these substances, the participant using CA was unable to identify
any of these components. The error rates for IR were between 0% and 86%, depending on the
substance.
In the current study, only 56% (5 of 9) of the participants fulfilled the quality requirements
of at least 99 points (Fig 1).
Table 2. (Continued)
Lab A Lab B Lab C Lab D Lab E Lab F Lab G Lab H Lab I
XD IR IR IR IR IR IR IR CD
Sample Substances % % % % % % % % % %
False analysis - - - - - - - - - 100 NI
D Brushite 70 80 80 80 70 65 80 100 0 0
Whewellite 30 20 20 20 30 35 0 0 0 0
False analysis - - - - - - 20 CaOx - 100 WL 100 NI
Survey 5
A Apatite 70 60 30 50 40 80 60 100 80 0
Struvite 30 30 70 40 60 15 0 0 15 0
False analysis - 10 WH - 10 WH - 5 WH 40 MP - 5 PR 100 NI
B Uricite 70 50 80 60 50 60 0 0 85 0
Uric acid dihydrate 30 50 20 40 50 40 0 100 15 0
False analysis - - - - - - 100 UA - - 100 NI
C Calcite 100 100 100 100 100 100 100 100 0 0
False analysis - - - - - - - - 100 NI 100 NI
D Uricite 80 20 50 40 40 50 0 100 50 0
Whewellite 20 80 50 60 60 50 0 0 50 0
False analysis - - - - - - 55 UA - - 100 NI
False analysis - - - - - - 45 CaOx - - -
Survey 6
A Uricite 70 70 60 70 60 60 0 0 80 0
Whewellite 30 30 40 30 40 40 0 0 20 0
False analysis - - - - - - 45 CaOx 100 NI - 100 NI
False analysis - - - - - - 55 UA - - -
B Struvite 70 50 70 70 70 55 0 35 40 0
Apatite 30 50 30 30 30 40 30 0 60 0
False analysis - - - - - 5 PR 70 MP 65 WL - 100 NI
C Brushite 60 80 60 50 30 45 80 0 0 0
Apatite 40 20 40 50 70 55 20 65 30 0
False analysis - - - - - - - 35 ST 70 WL 100 NI
D Sucrose 100 100 100 100 100 100 100 0 0 0
False analysis - - - - - - - 100 NI 100 NI 100 NI
AF: artifact; AP: apatite; BR: brushite; CaOx: calcium oxalate (simpliﬁed analysis result); CP: calcium phosphate (simpliﬁed analysis result); CY: cystine;
MP: magnesium ammonium phosphate (simpliﬁed analysis result); MU: monoammonium urate; NI: non-identiﬁable; PR: protein; ST: struvite; UA: uric acid
(simpliﬁed analysis result); UD: uric acid dihydrate; WD: weddellite; WH: whewellite; WL: whitlockite
doi:10.1371/journal.pone.0156606.t003
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Table 3. Error rates of qualitative analysis for test substances.
Substances Incorrect qualitative analysis (%) Total
IR (n = 7) CA (n = 1) XD (n = 1)
Substances in mixtures
Calcium oxalate monohydrate (whewellite) 32.9% (23/70) 90% (9/10) 0% (0/10) 35.6% (32/90)
Calcium oxalate dihydrate (weddellite) 28.6% (2/7) 100% (1/1) 0% (0/1) 33.3% (3/9)
Apatite 4.1% (2/49) 100% (7/7) 0% (0/7) 14.3% (9/63)
Calcium hydrogen phosphate dihydrate (brushite) 14.3% (3/21) 100% (3/3) 0% (0/3) 22.2% (6/27)
Magnesium ammonium phosphate hexahydrate (struvite) 17.9% (5/28) 100% (4/4) 0% (0/4) 25% (9/36)
Uric acid 22.9% (8/35) 80% (4/5) 0% (0/5) 26.7% (12/45)
Uric acid dihydrate 35.7% (5/14) 100% (2/2) 0% (0/2) 38.9% (7/18)
Cystine 7.1% (1/14) 0% (0/2) 0% (0/2) 6.3% (1/16)
Pure substances
Calcium carbonate (calcite) 14.3% (2/14) 100% (2/2) 0% (0/2) 22.2% (4/18)
Calcium phosphate (whitlockite) 85.7% (6/7) 100% (1/1) 0% (0/1) 77.8% (7/9)
Cholesterol 28.6 (4/14) 100% (2/2) 0% (0/2) 33.3% (6/18)
Monopotassium urate 42.9 (3/7) 100% (1/1) 0% (0/1) 44.4% (4/9)
Monosodium urate monohydrate 0% (0/7) 100% (1/1) 0% (0/1) 11.1% (1/9)
Sucrose 28.6% (2/7) 100% (1/1) 0% (0/1) 33.3% (3/9)
doi:10.1371/journal.pone.0156606.t004
Fig 1. Evaluation of analytical results of laboratories (maximum: 132 points; minimum: 99 points).
doi:10.1371/journal.pone.0156606.g001
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Discussion
Appropriate and thorough analysis of urinary stone composition is the most crucial laboratory
diagnostic procedure and the basis for dietary and medical treatment of the stone-forming
patient [7,9,14]. Compositional stone analysis should, therefore, be an integral part of the meta-
bolic evaluation of patients with urolithiasis [15]. Incorrect analysis or failure to identify a
stone substance may result in inadequate therapy.
Two previous studies based on the analysis of more than 50,000 and 200,000 urinary stones,
respectively, revealed a significant increase in the occurrence of brushite stones during recent
years [16,17]. Brushite stones are known to grow rapidly with a correspondingly very high
recurrence rate. Effective treatment is therefore highly important in brushite stone disease [18].
Additionally, the composition of a stone can be an important factor in its fragility. Due to their
hardness, brushite and whewellite (calcium oxalate monohydrate) have been shown to respond
poorly to disintegration by Extracorporeal Shock Wave Lithotripsy (ESWL) [7,19]. Whewellite
is among the most common urinary stone substances. The correct qualitative determination
and differentiation of whewellite and brushite is therefore essential for a selective approach to
stone therapy. The participant using CA was unable to identify whewellite in 90% of the analy-
ses, but incorrect results were also found in one third of analyses (33%) using IR. While the lab-
oratory with CA could not detect brushite, IR showed incorrect results in 14% of the analyses.
The participant with XD correctly reported brushite and whewellite in each sample.
Compared to brushite, the mixture of uric acid and uric acid dihydrate is relatively com-
mon. A recent study based on the analysis of 43,545 stones found that uric acid stone composi-
tion increased markedly in both sexes above the age of 50 years [20]. The differentiation
between uric acid and uric acid dihydrate can provide valuable information regarding the path-
ogenesis of the stone, because uric acid dihydrate is formed in very acidic urine [9]. While
more than 70% of all analyses reliably recorded uric acid, only 61% of laboratories correctly
detected the component uric acid dihydrate. CA was unable to identify uric acid dihydrate;
however, 5 of 14 (36%) of analyses using IR also failed.
Among the pure substances, only monosodium urate monohydrate, a rare urinary stone
component, was correctly determined by IR. On the contrary, laboratories using IR were
unable to identify whitlockite (calcium phosphate) in 86% of the analyses. Whereas XD showed
correct analyses of all pure substances, the error rate of CA was 100%.
It is not only undetected urinary stone components that may lead to inaccurate diagnosis
and subsequent inadequate recurrence prevention, but also false-positive analysis of substances
that are not present in the stone. For instance, incorrect analysis specifying the urinary calculus
substance cystine or magnesium ammonium phosphate instead of cholesterol is more detri-
mental to the patient than the statement “not identifiable”.
Several studies revealed that CA exhibits very high error rates of up to 94%, depending on
the stone component [10,21,22]. Our study in nine European laboratories confirms the high
error rates with the application of CA in the analysis of pure substances as well as mixtures.
Regarding the most common stone components (i.e. whewellite, uric acid and apatite), the
error rate for CA was between 80 and 100%. According to the current standard, CA is consid-
ered to be insufficient for stone analysis, whereas IR or XD is mandatory [7,10]. Among the dif-
ferent methods for urinary stone analysis, chemical analysis has been traditionally used most
widely due to its low cost. While XD requires more expensive equipment than IR, the advan-
tage of IR is the moderate cost.
Surprisingly, the evaluation of the results of our study revealed high error rates for both
pure substances and mixtures also in laboratories using IR, which is in contrast to previous
findings [10,21,22]. Of the 7 laboratories that used IR, just 4 (57%) fulfilled the quality
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requirements. Except for uric acid dihydrate, which is difficult to identify by IR in a mixture
with uric acid, all other pure substances and mixtures would have been expected to be correctly
detected. The results of our study showed that high performance can also be achieved by IR,
but it requires the use of sophisticated equipment and qualified personnel. Most computer pro-
grams for the automated evaluation of IR spectra and XD diagrams are considered to provide
unreliable component identification of mixtures [23]. The quality of the library of reference
spectra is regarded as the major factor contributing to the reliability of the evaluation software
[13]. Evaluation of the analysis carried out using IR and XD should always be checked by quali-
fied personnel [10]. The results underline previous findings that the equipment, reference spec-
tra and trained staff are indispensable preconditions for an accurate application of IR [10,13].
Conclusions
Targeted recurrence prevention requires reliable information on stone composition. For labo-
ratories that are not able to offer sophisticated analysis techniques and interpretative expertise,
referral or centralisation of stone analysis seems to be the only recommendable approach.
In order to ensure reliable results, measures for quality control of urinary stone analysis are
required. Among the five laboratories in Europe that fulfilled the quality requirements, four of
these laboratories had already participated in previous quality control surveys for urinary cal-
culi analyses. It can be concluded that regular quality control is essential in carrying out routine
stone analysis
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